Ryan Specialty Holdings, Inc.
Ryan Specialty Holdings, Inc. (RYAN) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Ryan Specialty Holdings, Inc. (RYAN), covering cash flow, earnings, and balance sheets.
Ryan Specialty Holdings, Inc. (RYAN) Income Statement & Financial Overview
View the income breakdown for Ryan Specialty Holdings, Inc. RYAN across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $690.17M | $663.53M | $604.69M | $701.95M |
| Cost of Revenue | $0.00 | $410.25M | $393.25M | $406.20M |
| Gross Profit | $690.17M | $253.28M | $211.44M | $295.75M |
| Gross Profit Ratio | $1.00 | $0.38 | $0.35 | $0.42 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $536.35M | $104.53M | $88.68M | $497.02M |
| Operating Expenses | $639.13M | $594.49M | $129.97M | $121.39M |
| Total Costs & Expenses | $639.13M | $594.49M | $523.22M | $494.66M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $54.51M | $48.53M | $49.39M | $31.13M |
| Depreciation & Amortization | $67.62M | $63.10M | $41.65M | $32.81M |
| EBITDA | $173.17M | $180.67M | $81.48M | $210.26M |
| EBITDA Ratio | $0.25 | $0.27 | $0.13 | $0.30 |
| Operating Income | $51.04M | $109.32M | $81.48M | $207.28M |
| Operating Income Ratio | $0.07 | $0.16 | $0.13 | $0.30 |
| Other Income/Expenses (Net) | $0.00 | -$40.28M | -$61.80M | -$27.64M |
| Income Before Tax | $51.04M | $69.04M | $19.68M | $136.73M |
| Income Before Tax Ratio | $0.07 | $0.10 | $0.03 | $0.19 |
| Income Tax Expense | $55.43M | $26.49M | -$8.96M | $18.69M |
| Net Income | -$27.64M | $13.75M | $17.59M | $46.79M |
| Net Income Ratio | -$0.04 | $0.02 | $0.03 | $0.07 |
| EPS | -$0.22 | $0.35 | $0.21 | $0.38 |
| Diluted EPS | -$0.22 | $0.05 | $0.09 | $0.37 |
| Weighted Avg Shares Outstanding | $126.03M | $125.41M | $121.92M | $118.39M |
| Weighted Avg Shares Outstanding (Diluted) | $126.03M | $1.33B | $272.69M | $271.22M |
The company's financials show resilient growth, with revenue advancing from $701.95M in Q2 2024 to $690.17M in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 42% in Q2 2024. Operating income hit $51.04M last quarter, sustaining a consistent 7% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $173.17M. Net income dropped to -$27.64M, while earnings per share reached -$0.22. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan